Correction: Corrigendum: CRISPR-Cas9 mediated efficient PD-1 disruption on human primary T cells from cancer patients
Crossref DOI link: https://doi.org/10.1038/srep40272
Published Online: 2017-01-19
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Su, Shu
Hu, Bian
Shao, Jie
Shen, Bin
Du, Juan
Du, Yinan
Zhou, Jiankui
Yu, Lixia
Zhang, Lianru
Chen, Fangjun
Sha, Huizi
Cheng, Lei
Meng, Fanyan
Zou, Zhengyun
Huang, Xingxu
Liu, Baorui
Text and Data Mining valid from 2017-01-19
Version of Record valid from 2017-01-19
Article History
First Online: 19 January 2017